Search

Information for healthcare professionals: Genetic testing and counselling in inherited retinal disease

Opus Genetics has launched an early-stage clinical trial of OPGx-MERTK, an investigational gene therapy for MERTK-related Retinitis Pigmentosa (RP), a condition that causes progressive vision loss due to photoreceptor degeneration.

• News
• Retinitis pigmentosa

In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).

• News
• Usher syndrome

Jing Yu is a bioinformatician with the Eye Research Group at Oxford University, and is part of the UK Inherited Retinal Dystrophy Consortium (UKIRDC) team, funded by a Retina UK  grant.

• News

A huge thank you to everyone who completed our 2025 sight loss survey. This year we received over 600 responses. It follows similar surveys in 2019 and 2022 which led directly to the introduction of our Unlock Genetics and Discover Wellbeing resources, as well as shaping our work with the professional community who support people with inherited sight loss.

• News

Tribute to Retina UK founder Lynda Cantor MBE

• News

Thank you to all those who completed our recent Sight Loss Survey – almost 700 of you took the time to share your experiences.

• News

Our monthly e-Newsletter featuring the latest updates from Retina UK.

• e-Newsletter
• Audio
• Written

Saturday 25 July, 12.00pm - 4.00pm - In-person - Please come and join facilitator Perm Bhachu and the group for their latest in-person social catch up over lunch at The Old House at Home pub in Harborne.

• Local Peer Support Group

Whether you are looking for practical information or emotional support, online, by phone or face-to-face, we’re here to help.